Authors:
SINUES B
SAENZ MA
LANUZA J
BERNAL ML
JUSTE JL
FANLO A
Citation: B. Sinues et al., COMPARISON OF 5 METABOLIC RATIOS AND 2 SAMPLING TIMES TO ASSESS CYP1A2 ACTIVITY USING CAFFEINE AS PROBE DRUG, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 64-64
Authors:
SINUES B
GAZULLA J
BERNAL ML
LANUZA J
FANLO A
SAENZ MA
BARTOLOME M
Citation: B. Sinues et al., 6 MUTAGENICITY ASSAYS IN EXPOSURE BIOMONITORING OF PATIENTS RECEIVINGCARBAMAZEPINE FOR EPILEPSY OR TRIGEMINAL NEURALGIA, Mutation research. Section on environmental mutagenesis and related subjects, 334(2), 1995, pp. 259-265
Authors:
SINUES B
RUEDA P
BENITEZ J
SAENZ MA
BERNAL ML
LANUZA J
ALDA O
TRES A
BARTOLOME M
Citation: B. Sinues et al., THIOETHER EXCRETION, URINARY MUTAGENICITY, AND METABOLIC PHENOTYPE INSMOKERS, Journal of toxicology and environmental health, 43(3), 1994, pp. 327-338
Authors:
HUERVA V
SINUES B
DELBUEY MA
CRISTOBAL JA
MINGUEZ E
LANUZA J
PALOMAR A
Citation: V. Huerva et al., LEVELS OF VANCOMYCIN IN AQUEOUS-HUMOR AFTER TOPICAL EYE DROPS ADMINISTRATION, Journal of ocular pharmacology, 9(2), 1993, pp. 167-170
Authors:
SINUES B
BARRA A
BERNAL ML
JIMENEZ A
LANUZA J
MAYAYO E
Citation: B. Sinues et al., CYTOGENETIC BIOMARKERS OF EXPOSURE TO MUTAGENS AND GLYCOSYLATED HEMOGLOBIN IN INSULIN-DEPENDENT DIABETIC-PATIENTS, MUTATION RESEARCH, 291(3), 1993, pp. 272-272
Authors:
SINUES B
BROTO A
SUAREZ MA
SAENZ MA
LANUZA J
BERNAL ML
Citation: B. Sinues et al., CYTOGENETIC STUDY IN PERIPHERAL-BLOOD LYMPHOCYTES FROM ASTHMATIC-PATIENTS RECEIVING CONTINUED THERAPY WITH THEOPHYLLINE, MUTATION RESEARCH, 291(3), 1993, pp. 272-273
Authors:
SINUES B
MAYAYO E
BERNAL ML
LANUZA J
SAENZ MA
FERRANDEZ A
Citation: B. Sinues et al., BIOLOGICAL INDICATORS OF EXPOSURE TO MUTAGENS CARCINOGENS IN GH DEFICIENT CHILDREN UNDERGOING TREATMENT WITH RECOMBINANT GH, MUTATION RESEARCH, 291(3), 1993, pp. 273-273
Authors:
BERNAL ML
ANSON JL
SINUES B
SAENZ MA
LANUZA J
BARTOLOME M
Citation: Ml. Bernal et al., BIOMONITORING OF EXPOSURE TO GENOTOXIC AGENTS AND TUMORAL MARKERS IN UREMIC PATIENTS UNDERGOING HEMODIALYSIS, MUTATION RESEARCH, 291(3), 1993, pp. 291-291